The Contributions of Gamma Probe to Lesion Detectability and Surgical Safety in Recurrent Thyroid Cancer at Risk | Zendy

Salih Sinan Gültekin | Zendy; Güleser Saylam | Zendy; Tuncay Delibaşı | Zendy; Hakan Korkmaz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Contributions of Gamma Probe to Lesion Detectability and Surgical Safety in Recurrent Thyroid Cancer at Risk

Author(s) -

Salih Sinan Gültekin,

Güleser Saylam,

Tuncay Delibaşı,

Hakan Korkmaz

Publication year - 2013

Publication title -

molecular imaging and radionuclide therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.292

H-Index - 7

eISSN - 2147-1959

pISSN - 2146-1414

DOI - 10.4274/mirt.148

Subject(s) - medicine , thyroid cancer , thyroid , lesion , thyroid carcinoma , radioiodine therapy , cancer , radiology , surgery

In patients, who underwent thyroid surgery or treated with I-131 radioiodine previously for differentiated thyroid cancer, a second surgical intervention carries higher risks due to distortion of the natural anatomy and development of fibrotic/cicatricial tissue. In addition, accurate assessment of current status about extent of the disease is important in terms of success of the surgery. In this case report, we present the positive contribution of intraoperative gamma probe used for lesion detectability and for surgical safety in a patient operated for several times and administered high cumulative dose of radioiodine therapy for diffentiated thyroid carcinoma previously.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research